CLOs on the Move

Central Georgia Health Network

www.mycghn.com

 
CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mycghn.com
  • 111 Perimeter Parkway
    Macon, GA USA 31210
  • Phone: 478.832.6134

Executives

Name Title Contact Details

Similar Companies

Hallmark Palm Springs

Hallmark Palm Springs is a Palm Springs, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Pathway to Living

Since 1997, Pathway to Living has been helping older adults fulfill dreams and accomplish goals – every day. People are choosing Pathway as home because they need someone to guide them down their path, not stand in the way. We are the new generation of senior living – a tailored wellness program accompanied with a vibrant and inspirational way of living is what sets Pathway to Living apart from the rest. Join the movement, discover your Pathway.

Gwc Technologies Inc

Gwc Technologies Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EngageMED

Our mission at EngageMED is to provide innovative, value-based practice management and revenue cycle services to providers we engage throughout the state of Arkansas.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.